Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia

NCT01106716 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Postherpetic Neuralgia

Interventions

DRUG: Placebo
DRUG: KAI-1678
DRUG: Lidocaine

Sponsor

KAI Pharmaceuticals

Collaborators

[object Object]